{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:15:23Z","timestamp":1784632523024,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.mehy.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T02:44:21Z","timestamp":1536201861000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle"],"prefix":"10.1016","volume":"121","author":[{"given":"Lubna","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5301-5298","authenticated-orcid":false,"given":"Sushama","family":"Talegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2018.09.003_b0005","first-page":"240","article-title":"Mouse models for colorectal cancer","volume":"3","author":"Karim","year":"2013","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.mehy.2018.09.003_b0010","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"issue":"1\u201342","key":"10.1016\/j.mehy.2018.09.003_b0015","first-page":"vii","article-title":"The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps","volume":"89","author":"Cappell","year":"2005","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.mehy.2018.09.003_b0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.mehy.2018.09.003_b0025","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(02)09290-5","article-title":"Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial","volume":"359","author":"Lacy","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2018.09.003_b0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3748\/wjg.v22.i2.582","article-title":"Insight to drug delivery aspects for colorectal cancer","volume":"22","author":"Gulbake","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2018.09.003_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000091441","article-title":"Chemotherapy for colorectal cancer","volume":"22","author":"Goyle","year":"2005","journal-title":"Dig Surg"},{"key":"10.1016\/j.mehy.2018.09.003_b0040","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM199404213301608","article-title":"Chemotherapy for colorectal cancer","volume":"330","author":"Moertel","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.003_b0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","article-title":"Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy","volume":"17","author":"Parhi","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mehy.2018.09.003_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.mehy.2018.09.003_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/1061186X.2012.702767","article-title":"Role of CD44 in tumour progression and strategies for targeting","volume":"20","author":"Negi","year":"2012","journal-title":"J Drug Target"},{"key":"10.1016\/j.mehy.2018.09.003_b0060","first-page":"4754","article-title":"Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression","volume":"53","author":"Wielenga","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2018.09.003_b0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","article-title":"Hyaluronan\u2013CD44 interactions as potential targets for cancer therapy","volume":"278","author":"Misra","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.mehy.2018.09.003_b0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.colsurfb.2014.09.062","article-title":"Surface engineered nanostructured lipid carriers for targeting MDR tumor: part I. Synthesis, characterization and in vitro investigation","volume":"123","author":"Negi","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mehy.2018.09.003_b0075","first-page":"605","article-title":"Surface engineered nanostructured lipid carriers for targeting MDR tumor: part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies","volume":"123","author":"Negi","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mehy.2018.09.003_b0080","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","article-title":"Mechanisms of drug resistance in colon cancer and its therapeutic strategies","volume":"22","author":"Hu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2018.09.003_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(02)00175-8","article-title":"Considerations in the design and development of transport inhibitors as adjuncts to drug therapy","volume":"55","author":"Dantzig","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.mehy.2018.09.003_b0090","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1158\/1535-7163.MCT-12-0966","article-title":"Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump","volume":"12","author":"Mazard","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.mehy.2018.09.003_b0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2008.06.007","article-title":"Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein","volume":"83","author":"Bansal","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2018.09.003_b0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-7158.2011.01391.x","article-title":"Everted gut sac model as a tool in pharmaceutical research: limitations and applications: everted gut sac model","volume":"64","author":"Alam","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mehy.2018.09.003_b0105","first-page":"37","article-title":"Enhanced permeability of etoposide across everted sacs of rat small intestine by vitamin E-TPGS","volume":"12","author":"Parsa","year":"2013","journal-title":"Iran J Pharm Res IJPR"},{"key":"10.1016\/j.mehy.2018.09.003_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-5173(03)00372-7","article-title":"Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs","volume":"263","author":"Faassen","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mehy.2018.09.003_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/S15327914NC3701_1","article-title":"Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects","volume":"37","author":"Conklin","year":"2000","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.mehy.2018.09.003_b0120","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2018.09.003_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4251\/wjgo.v6.i3.55","article-title":"The role of antioxidants and pro-oxidants in colon cancer","volume":"6","author":"Stone","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.mehy.2018.09.003_b0130","article-title":"Dietary total antioxidant capacity and colorectal cancer in the Italian EPIC cohort","author":"Vece","year":"201510","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2018.09.003_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ultsonch.2016.09.001","article-title":"Aerosol assisted self-assembly as a route to synthesize solid and hollow spherical lignin colloids and its utilization in layer by layer deposition","volume":"35","author":"Mishra","year":"2017","journal-title":"Ultrason Sonochem"},{"key":"10.1016\/j.mehy.2018.09.003_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/01635589809514637","article-title":"Free radical-scavenging properties of lignin","volume":"30","author":"Lu","year":"1998","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.mehy.2018.09.003_b0145","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cej.2017.07.022","article-title":"pH-responsive lignin-based complex micelles: preparation, characterization and application in oral drug delivery","volume":"327","author":"Li","year":"2017","journal-title":"Chem Eng J"},{"key":"10.1016\/j.mehy.2018.09.003_b0150","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1021\/acssuschemeng.7b01903","article-title":"Lignin nanoparticle as a novel green carrier for the efficient delivery of resveratrol","volume":"5","author":"Dai","year":"2017","journal-title":"ACS Sustain Chem Eng"},{"key":"10.1016\/j.mehy.2018.09.003_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-4347(94)00340-8","article-title":"Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma","volume":"661","author":"Rivory","year":"1994","journal-title":"J Chromatogr B Biomed Sci App"},{"key":"10.1016\/j.mehy.2018.09.003_b0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ctrv.2006.07.001","article-title":"Irinotecan in the treatment of colorectal cancer","volume":"32","author":"Fuchs","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.mehy.2018.09.003_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0027-5107(95)00105-0","article-title":"Studies on the role of specific dietary fibres in protection against colorectal cancer","volume":"350","author":"Ferguson","year":"1996","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"10.1016\/j.mehy.2018.09.003_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pmatsci.2017.12.001","article-title":"Properties and chemical modifications of lignin: towards lignin-based nanomaterials for biomedical applications","volume":"93","author":"Figueiredo","year":"2018","journal-title":"Prog Mater Sci"},{"key":"10.1016\/j.mehy.2018.09.003_b0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijbiomac.2017.05.103","article-title":"An overview of natural renewable bio-polymer lignin towards nano and biotechnological applications","volume":"103","author":"Roopan","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.mehy.2018.09.003_b0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.indcrop.2007.07.011","article-title":"Potential applications of antioxidant lignins from different sources","volume":"27","author":"Vinardell","year":"2008","journal-title":"Ind Crops Prod"},{"key":"10.1016\/j.mehy.2018.09.003_b0185","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.indcrop.2016.09.061","article-title":"Antioxidant and antibacterial lignin nanoparticles in polyvinyl alcohol\/chitosan films for active packaging","volume":"94","author":"Yang","year":"2016","journal-title":"Ind Crops Prod"},{"key":"10.1016\/j.mehy.2018.09.003_b0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/dmd.30.7.763","article-title":"Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.mehy.2018.09.003_b0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18433\/J3RC77","article-title":"Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy","volume":"12","author":"Bansal","year":"2009","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.mehy.2018.09.003_b0200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/10717544.2014.923956","article-title":"Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations","volume":"23","author":"Fatma","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.mehy.2018.09.003_b0205","first-page":"857","article-title":"Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin","volume":"15","author":"Borska","year":"2010","journal-title":"Mol Basel Switz"},{"key":"10.1016\/j.mehy.2018.09.003_b0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.colsurfb.2013.06.001","article-title":"Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation","volume":"111","author":"Negi","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mehy.2018.09.003_b0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jddst.2015.05.003","article-title":"Potential of a novel self nanoemulsifying carrier system to overcome P-glycoprotein mediated efflux of etoposide: in vitro and ex vivo investigations","volume":"28","author":"Akhtar","year":"2015","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.mehy.2018.09.003_b0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nut.2012.02.014","article-title":"Role of antioxidants in cancer therapy","volume":"29","author":"Fuchs-Tarlovsky","year":"2013","journal-title":"Nutr Burbank Los Angel Cty Calif"},{"key":"10.1016\/j.mehy.2018.09.003_b0225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","article-title":"Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine","volume":"23","author":"Mattheolabakis","year":"2015","journal-title":"J Drug Target"},{"key":"10.1016\/j.mehy.2018.09.003_b0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2018.04.015","article-title":"Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system","volume":"278","author":"Huang","year":"2018","journal-title":"J Controlled Release"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718306893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718306893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T11:54:23Z","timestamp":1544183663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718306893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"alternative-id":["S0306987718306893"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.09.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}